Medlumics — Series E · €14M

Medlumics makes medical devices and is developing the AblaView cardiac ablation system, which uses photonics and optical imaging. It closed a €14M Series E co-led by Asabys Partners (through Sabadell Asabys Health Innovation Investments), VI Partners and CDTI Innvierte, with existing investors Andera Partners, Caixa Capital Risc and Innogest joining. The money will finish preclinical work and produce the first data in humans.